Endometrial cancers with activating kras mutations have activated estrogen signaling and paradoxical response to MEK inhibition

Kari L. Ring, Melinda S. Yates, Rosemarie Schmandt, Michaela Onstad, Zhang Qian, Joseph Celestino, Suet Ying Kwan, Karen H. Lu

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Endometrial cancers with activating kras mutations have activated estrogen signaling and paradoxical response to MEK inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences